Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROQ-IT: Transition from Mircera to Daprodustat in ESKD
NCT05951192Phase 4Completed
- Sponsor
- U.S. Renal Care
- Start
- Jul 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by U.S. Renal Care. Started Jul 2023; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT05951192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05951192.